Sentences with phrase «effect on cardiovascular disease»

Recent research shows that artificially lowering blood pressure with drugs has virtually no effect on cardiovascular disease risk, compared to lowering readings with natural fruit polyphenols, diet and physical activity.

I am not saying that some oils can be healthy, but maybe curtains oils can have a smaller effect on cardiovascular disease, but maybe a more neutral one?

Yes, there have been studies that show coconut oil does have the ability to raise LDL cholesterol, but what the AHA didn't mention is the countless studies that show how incredibly effective coconut oil is at raising HDL cholesterol, providing a protective effect on cardiovascular disease.

Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects?

There are two recent human studies, one showing an effect on cardiovascular disease and one Kaiser Permanente study on workers in China (in polycarbonate - manufacturing plants) showing effects on male sexual function.

Higher dairy consumption has been associated with beneficial effects on cardiovascular disease - related comorbidities such as hypertension, type 2 diabetes, and insulin resistance.

Not exact matches

A new, extensive five - year study on the effects of cocoa flavanols on cardiovascular disease is slated to begin in 2015 and will hopefully reveal more about the antioxidant's impact on memory.

Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention

The study concluded that including nuts within a healthy dietary pattern may have favorable effects on endothelial dysfunction, which is associated with cardiovascular disease.

Eating butter has no effect on raising cardiovascular disease (CVD) risk and may even have protective effects against diabetes, according to a review.

The effects of a whole grain - enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome.

This observation has precipitated numerous observational studies and randomized controlled trials of the effect of added sugars or SSB consumption on body weight and cardiovascular disease risk factors (6, 8, 9).

Of note, our models may underestimate the true maternal costs of suboptimal breastfeeding; we modeled the effects of lactation on only five maternal health conditions despite data linking lactation with other maternal health outcomes.46 In addition, women in our model could not develop type 2 diabetes mellitus, hypertension, or MI before age 35 years, although these conditions are becoming increasingly prevalent among young adults.47 Although some studies have found an association between lactation and rates of postmenopausal diabetes22, 23 and cardiovascular disease, 10 we conservatively limited the duration of lactation's effect on both diabetes and MI.

The authors note that the different relationships between alcohol intake and various types of cardiovascular disease may relate to alcohol's elevating effects on blood pressure and on factors related to elevated high - density lipoprotein cholesterol (HDL - C)(also known as «good» cholesterol).

«Trans - fatty acids increase LDL cholesterol [our «bad» cholesterol], and they don't have much of an effect on HDL [our «good» cholesterol],» contributing to cardiovascular disease risk, says Alice Lichtenstein, a nutritional biochemist at Tufts University in Boston, who published a review on the topic in Current Atherosclerosis Reports in June 2014.

As pharmacologists, our interest is primarily in the mechanisms and therapeutics of ischemic heart diseases, and we have been working on the cardiovascular effects of herbs according to modern scientific criteria.

The genetic variants associated with asthma have also effects on autoimmune diseases and other diseases with an inflammatory component such as cardiovascular diseases, cancers, neuro - psychiatric diseases, which strengthens the importance of pleiotropy in multifactorial diseases.

The most investigated of those are a group of hormonelike polyphenols called isoflavones, which seem to have effects on everything from kidney and cardiovascular disease and various cancers to hot flashes, bone calcium loss and other symptoms of menopause.

DiNicolantonio recently co-wrote a review of studies, published in the journal, about the effects of salt and sugar on high blood pressure and cardiovascular disease.

«Specifically, we are looking at the effects of these early factors on later levels of C - reactive protein (CRP), a biomarker associated with risk for cardiovascular and metabolic disease,» Metzger said.

Dr Andersen said the study was important because, although there have been other studies looking at the effects of endurance exercise on various cardiovascular problems such as ischemic heart disease and stroke, there have been only a few, smaller studies of its effect on heart rhythm disturbances, and they have tended to look at people who are less physically active, or compared very sedentary people with those who were very active.

Last year's press release (Dutch) described a meta - analysis of 17 studies about the effects of milk and dairy consumption on cardiovascular disease and mortality by researchers at WUR, Harvard, and the University of California, San Diego.

We investigated the effects of coffee and tea on CV mortality and non-CV mortality in a large French population at low risk of cardiovascular diseases.»

Previous research has shown that being sedentary increases the risk of cardiovascular disease but until now its effect on patients with established heart disease was unknown.

Appel and Sacks led three earlier clinical trials that tested ways to reduce the risk of cardiovascular disease and diabetes, providing volunteers with carefully designed diets and measuring the effects on key health indicators.

Although there was no effect of dietary sodium on blood pressure for those in the low range, there were more deaths and cases of cardiovascular disease outcomes.

The study shows that even low physical fitness, up to 20 % below the average for healthy people, is sufficient to produce a preventive effect on most of the risk factors that affect people with cardiovascular disease.

«More studies are required in order to make these important associations in terms of the effects of supplementation on cardiometabolic syndrome, the immune and inflammatory mechanisms of cardiovascular disease in postmenopausal women, and their quality of life,» Nahas said.

The results showed that normal physical fitness, even up to 20 % below the population average, is sufficient to have a preventive effect on five of the eight risk factors affecting people with cardiovascular disease — abdominal circumference, diabetes, hypertension, obesity, and excess weight.

Globorisk measures cardiovascular risk in individuals aged 40 or older by factoring in the person's smoking status, blood pressure, diabetes status, and total cholesterol level, whilst adjusting for the effects of sex and age on cardiovascular disease between countries.

The panel concluded, among other things, that yoghurt and cheese have a different and more beneficial effect on bone health, body weight, the risk of developing cardiovascular diseases, than would be expected on the basis of their saturated fat and calcium content.

In this review topic, researchers looked at novel translational noise studies demonstrating the molecular mechanisms that may lead to impaired vascular function, recent epidemiologic evidence of noise - induced cardiovascular disease, and the non-auditory effects of noise and their impact on the cardiovascular system.

Depression, even when undiagnosed, can have many negative effects on cardiovascular patients, including poor healthcare experiences, more use of healthcare resources and higher health costs, according to preliminary research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2018, a premier global exchange of the latest advances in quality of care and outcomes research in cardiovascular disease and stroke for researchers, healthcare professionals and policymakers.

For example, a researcher interested in cardiovascular disease may only want to examine the effect of a disrupted gene on blood pressure.

But overall, the findings challenge the widespread assumption that moderate drinking has a beneficial effect on the mortality rate of cardiovascular diseases.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

This study looks at the effects of intense, brief exercise in comparison to traditional endurance exercise on cardiovascular disease markers in younger individuals.

According to a study published in the European Journal of Preventive Cardiology, aromatherapy has a beneficial effect on heart rate and blood pressure in both men and women, and may reduce the risk of cardiovascular disease.

These benefits are widely acknowledged to have a multitude of healthy flow - on effects, including the ability to lower cholesterol levels, blood pressure and blood glucose levels, improve respiratory function and even reduce the risk of cardiovascular disease.

However, researchers in the Department of Animal Science at Texas A&M University have published the only two research studies that actually compared the effects of ground beef from grass - fed cattle and traditional, grain - fed cattle on risk factors for cardiovascular disease (CVD) and type II diabetes in men.

Now it exists in multiple forms in most of the prepared food available to us (even the sugar - free options) and it perpetuates overall inflammation, dumps fat on our liver (non-alcoholic fatty liver disease); makes our cells resistant to the effects of insulin (insulin resistant); and then gives us metabolic syndrome, abdominal obesity, cardiovascular disease and type II diabetes.

It's also an anti-inflammatory agent that protects against cardiovascular disease, arrhythmias and sudden death after heart attack.1 And if that weren't impressive enough, berberine's up - and - coming claim to fame revolves around its truly remarkable effects on blood sugar and diabetes control.

«Diet has tremendous effects on our short - and long - term health, especially when it comes to obesity, diabetes, and heart disease,» says Dariush Mozaffarian, MD, associate professor of cardiovascular medicine at Harvard Medical School.

«The effects of protein intake on blood pressure and cardiovascular disease.»

27 Studies cited by the 2010 DGAC Report demonstrate varied metabolic responses to lowered dietary saturated fat, with certain subpopulations exhibiting adverse rather than improved health outcomes.3 Two recent comprehensive meta - analyses indicate that saturated fat is not linked to heart disease.28, 29 In fact, in a definitive review of forty - eight clinical trials, with over sixty - five thousand participants, the reduction or modification of dietary fat had no effect on mortality, cardiovascular mortality, heart attacks, stroke, cancer, or diabetes.30 Yet, avoiding saturated fat remains a cornerstone of national dietary guidance.

The book provides a deep dive into the relationship between mitochondrial health and cardiovascular diseases; cardiometabolic syndrome; neurodegenerative diseases; arthritis; cancer; and the aging effects on the skin, eyes, and muscles.

The problem is getting a handle on what exactly this means, particularly when these same changes seem to have no effect on lipid levels, and the risk of dying from cardiovascular disease is at best weakly associated with high salt consumption (15 % increase in risk).

In this episode Rhonda talks about how heat stress from using the sauna makes the body more resilient to the stresses of aging, possible reasons why one study associated sauna use with up to a 40 % lower all - cause mortality as well as a 50 % lower cardiovascular disease related mortality, how it enhances athletic endurance, staves off muscle atrophy, improves regrowth of muscle after disuse, and some of the profound effects on the brain, including the growth of new brain cells, improvement in focus, learning, and memory, and even potentially ameliorating depression and anxiety.

Cook NR, «Long term effect of dietary sodium reduction on cardiovascular disease outcomes: observational follow - up of the trials of hypertension prevention.

The research was inspired by studies that looked at the effect of diet and lifestyle changes on other diseases, such as cardiovascular disease, cancer, and HIV.